Testosterone Replacement Therapy Programs
Rugiet — a men's health company that surpassed 100 million dollars in revenue in 2025 and has treated over $400,000 — has launched a testosterone replacement therapy program that includes enclomiphene as well as oral, injectable, and topical options. This service is supported by comprehensive lab testing, physician evaluations, and individualized treatment plans for qualified patients.
Rugiet, which is best known for its three-in-one erectile dysfunction treatment called Ready, also introduced a new brand identity created with Pentagram and Alright Studio to signal its evolution into a broader performance-driven healthcare company for men.
The expansion of the testosterone replacement therapy program comes as research has documented generational declines in testosterone levels independent of aging, and a 2024 study found that prescription of testosterone treatments increased significantly among younger men.
- 來源
- Trend Hunter
- 發布
- 2026-04-19
- 品類
- Billboards
- 出處
- businesswire